PI
ZYME icon

Putnam Investments’s Zymeworks ZYME Stock Holding History

Putnam Investments’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$727K Sell
69,996
-2,219
-3% -$17.7K ﹤0.01% 882
2023
Q3 		$458K Buy
+72,215
New +$533K ﹤0.01% 935

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Putnam Investments's ZYME Position: Q4 2023 in Review

Putnam Investments reduced its Zymeworks (ZYME) stake by 3.1% in Q4 2023, selling an estimated $17.7K and leaving 69,996 shares worth $727K. The position accounts for ﹤0.01% of the portfolio, ranked #882.

Putnam Investments first reported a position in ZYME in Q3 2023 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold ZYME as of Q4 2023.

  • Putnam Investments held 69,996 shares of Zymeworks worth $727K as of Q4 2023.
  • Putnam Investments sold 2,219 Zymeworks shares in Q4 2023, an estimated $17.7K.
  • Zymeworks made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #882 holding.
  • Putnam Investments first reported a position in Zymeworks in Q3 2023 and has held it in 2 quarters since.
  • 157 funds tracked by Wall St. Rank held Zymeworks as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.